Generated by AI
Schrödinger, Inc. is a life sciences software and biotechnology company that develops a physics-based computational platform for molecular discovery. The company provides software tools used to model and simulate chemical and biological systems, helping researchers identify and optimize novel molecules for drug discovery and materials science. Its platform is used across the pharmaceutical, biotechnology, materials, and industrial research sectors, supporting workflows such as molecular design, simulation, and collaboration. Schrödinger also operates a drug discovery segment that applies its technology to proprietary and partnered research programs. Headquartered in New York and founded in 1990, Schrödinger plays a specialized role in the market as a provider of advanced computational chemistry solutions for scientific innovation.
Website1540 Broadway
New York, NY, 10036
United States
The latest articles about SDGR.
Schrodinger (SDGR) delivered earnings and revenue surprises of +24.24% and +40.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Summary of Nov 3's posts. Generated by AI.
Summary of Oct 28's posts. Generated by AI.
Summary of Feb 21's posts. Generated by AI.
Summary of Nov 3's posts. Generated by AI.
Investors talking about SDGR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.